PIONEERING
CELL & ANTIBODY-BASED
CANCER THERAPEUTICS
NEWS
'Alphageneron Announces Successful Completion of Pre-IND Meeting for ENKASTIM™ NK Cell Therapy with the US FDA on September 27 2021'
Harvard Square, One Mifflin Place, Suite 400
Cambridge, MA 02138, USA